Back to Results
First PageMeta Content
Anatomy / Combination drugs / Enantiopure drugs / Novartis / LCZ696 / Heart failure / Health care in Canada / Enalapril / Management of heart failure / Pharmacology / Medicine / ACE inhibitors


Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca
Add to Reading List

Document Date: 2015-05-13 10:22:09


Open Document

File Size: 263,67 KB

Share Result on Facebook

City

Ottawa / Toronto / Basel / Dorval / /

Company

Jean Kanan Spectrum Advisors Communications Inc. / Novartis International AG / Weston SA / Novartis Group / Novartis Pharmaceuticals Canada Inc. / Novartis AG / Dole / Novartis Pharmaceuticals Inc. / /

Country

Switzerland / Canada / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

American College / Canadian Institute / /

IndustryTerm

protective neurohormonal systems / treatment of heart failure / generic pharmaceuticals / healthcare field / healthcare solutions / /

MedicalCondition

About heart failure / systolic dysfunction / fatigue / Longo D. Disorders / Novartis’ heart failure / pancreatic cancer / congestive heart failure / cancer / disease / Canada Heart failure / heart failure / diseases / heart failure LCZ696 / /

Organization

Canadian Cancer Society / US Securities and Exchange Commission / Canadian Cancer Society’s Advisory Committee on Cancer Statistics / European Union Committee for Medicinal Products for Human Use / European Medicines Agency / the American College / FDA / Heart and Stroke Foundation of Canada / Canadian Institute for Health Information / /

Person

Tim Maloney / Patricia Tiramani / /

/

Position

President / leader / /

Product

LCZ696 / /

ProvinceOrState

Quebec / /

PublishedMedium

Drug Discovery Today / /

RadioStation

15 Heart / 2 Heart / /

Technology

pdf / Drug Discovery / /

URL

http /

SocialTag